Navigation Links
Chest news briefs: CPAP may cause facial changes


The use of a nasal continuous positive airway pressure (nCPAP) machine for more than 2 years may cause craniofacial changes in adults with obstructive sleep apnea (OSA). Researchers from The University of British Columbia, Vancouver, BC, Canada, analyzed baseline and follow-up radiographs from 46 Japanese patients with OSA who had used nCPAP for a minimum of 2 years. Changes in craniofacial structures were assessed. nCPAP use was associated with change in the craniofacial form by reducing maxillary and mandibular prominence and/or by altering the relationship between the two dental arches. There were no significant correlations between mean age, BMI, apnea-hypopnea index, or the average duration of nCPAP use (35.06.7 months) and the craniofacial changes. No patients reported any permanent craniofacial changes. Researchers conclude that the side effects of nCPAP use warrant more detailed studies over longer time periods, considering that nCPAP is often prescribed for long-term use. The article is published in the October issue of CHEST, the peer-reviewed journal of the American College of Chest Physicians: CHEST 2010; 138(4):870�.


Larger catheter size, prior DVT, and having a prior surgery lasting longer than 1 hour are associated with an increased risk for peripherally inserted central catheter (PICC)-associated DVT. PICCs are often used to provide long-term IV antibiotic therapy, chemotherapy, and total parenteral nutrition. Researchers from the University of Utah and Intermountain Healthcare analyzed a total of 2,014 PICCs inserted at a level 1 trauma center in order to understand risk factors for PICC-associated DVT. Factors that best predicted DVT included patients who had a prior DVT, those who underwent prior surgery of duration greater than 1 hour, and the use of double lumen-5 French or triple lumen 6-French catheters. Researchers conclude that rates of PICC-associated DVT may be reduced by an improved selection of patients and catheter size. This article is published in the October issue of CHEST, the peer-reviewed journal of the American College of Chest Physicians: CHEST 2010; 138(4):803�.


The application of new local coverage determination (LCD) adherence criterion for continued reimbursement of continuous positive airway pressure (CPAP) may have potential negative effects on patients with obstructive sleep apnea (OSA) and their clinical care. Researchers from National Jewish Health in Denver, Colorado, retrospectively examined a database of 150 patients who received neuropsychological testing prior to CPAP treatment and 3 to 6 months posttreatment. Patients were categorized using the new LCD criteria, and comparisons were made between adherent and nonadherent groups on neuropsychological variables. Fifty-five patients (37 percent) failed to meet the new criterion. Of the 63 patients who did not receive any special adherence intervention, 29 (46 percent) met the new criterion. Researchers conclude that controlled trials are needed to better understand the effect of the new guidelines on adherence and treatment outcomes. This article is published in the October issue of CHEST, the peer-reviewed journal of the American College of Chest Physicians: CHEST 2010; 138(4):875�.


Contact: Jennifer Stawarz
American College of Chest Physicians

Related medicine news :

1. Quick Chest Pain Test Simplifies Discharge Decision
2. Concentra, American Showa to Open Associates Health Center in Blanchester, Ohio
3. Kids Tai Chi Workout Premieres in Westchester, New York, March 2, 2010
4. News briefs from the March issue of Chest
5. Chest X-rays Can Help Predict Which H1N1 Patients Are at Greatest Risk
6. Chest X-rays can help predict which H1N1 patients are at greatest risk
7. News briefs from the April issue of Chest
8. Outcomes of patients dismissed from the hospital with non-cardiac chest pain
9. Researchers successfully lower radiation dose associated with pediatric chest CT scans
10. Noncardiac Chest Pain May Warrant More Management: Study
11. News briefs from the May issue of Chest
Post Your Comments:
(Date:11/27/2015)... ... November 27, 2015 , ... ... 27th edition of USA Today in Atlanta, Dallas, New York, Minneapolis, South Florida, ... The digital component is distributed nationally, through a vast social media strategy and ...
(Date:11/27/2015)... ... November 27, 2015 , ... A simply groundbreaking television ... an interesting show that delves into an array of issues that are presently affecting ... benefit from open dialogue, this show is changing the subjects consumers focus on, one ...
(Date:11/27/2015)... Santa Rosa, CA (PRWEB) , ... November 27, 2015 , ... ... Northern California Medical Associates, Inc. and Dr. Tucker Bierbaum with Emergency Medicine ... dinner meeting. They observed that both STEMI and Sepsis conditions present in similar ways ...
(Date:11/26/2015)... Toronto, ON and Cambridge, ON (PRWEB) , ... ... ... announced today the availability of a real-time eReferral system for diagnostic imaging in ... CTs, ultrasounds, X-rays, mammography, BMD and Nuclear Medicine tests directly from their electronic ...
(Date:11/26/2015)... Mass. (PRWEB) , ... November 26, 2015 , ... ... thorough second medical opinion process, participated in the 61st annual Employee Benefits Conference. ... Plans and took place Sunday, November 8th through Wednesday, November 11th, 2015. The ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... DUBLIN , November 26, 2015 /PRNewswire/ ... the addition of the "Radioimmunoassay Market ... User (Hospital, Pharmaceutical Industry, Academics, Clinical Diagnostic ... - Global Forecast to 2020" report ... ) has announced the addition of the ...
(Date:11/25/2015)...  Amgen (NASDAQ: AMGN ) today announced the ... the United States (U.S.) Food and ... to Humira ® (adalimumab). Amgen believes this submission ... FDA and represents Amgen,s first BLA submission using the ... M.D., executive vice president of Research and Development at ...
(Date:11/25/2015)... -- On Tuesday, November 24, 2015, the jury ... Medical Technology, Inc. for product liability and misrepresentation ... device, awarded $11 million in favor of Plaintiff ... three days of deliberations, the jury found that ... and unreasonably dangerous, and that Wright Medical made ...
Breaking Medicine Technology: